Меню
Идёт набор NCT06804525

LHC-CIDI-5 in Hong Kong

Наблюдательное Major Depressive Episode (MDE) Major Depressive Disorder (MDD) Persistent Depressive Disorder (PDD) Suicidal Ideation

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: CIDI-5, LHC-CIDI-5.
Кому может быть актуально
Состояния в реестре: Major Depressive Episode (MDE), Major Depressive Disorder (MDD), Persistent Depressive Disorder (PDD), Suicidal Ideation. Базовые параметры: от 25 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Гонконг
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Use of Life History Calendars to Enhance Measurement of Lifetime Experience With Mental Disorders in Hong Kong.

Обзор

The World Health Organization Composite International Diagnostic Interview-5th (CIDI-5) is a standardized diagnostic tool used to assess the prevalence of mental and substance use disorders over varying time frames (30 days, 12 months, and lifetime) based on the diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) and International Classification of Diseases 10th edition (ICD-10). However, retrospective measurements like the CIDI-5 are susceptible to recall bias, especially for the lifetime experience, which can hinder the reporting accuracy with mental disorders. To mitigate this issue, the life history calendar (LHC) was introduced as an aid to assist respondents in recalling the timing of life events, enhancing the ability of the CIDI-5 to measure the lifetime prevalence of mental disorders. The LHC is a grid structure with columns representing time units and rows representing life domains under study. In a study conducted in Nepal, combining the CIDI-5 with the LHC resulted in a significant increase in the detection of mental disorders compared to using the CIDI-5 alone. This approach did not lead to an increase in false positives after clinical validation. This experiment aims to adapt a Hong Kong version of the LHC based on the Nepalese model and evaluate the effectiveness of the LHC-assisted CIDI-5 (LHC-CIDI-5) compared to the CIDI-5 alone in assessing mental disorders.

Вмешательства

  • Диагностический тест CIDI-5
    The World Health Organization Composite International Diagnostic Interview-5th (CIDI-5) is a standardized diagnostic tool used to assess the prevalence of mental and substance use disorders over varying time frames (30 days, 12 months, and lifetime) based on the diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) and International Classification of Diseases 10th edition (ICD-10) . Trained interviewers will administrate selected modules fr
  • Диагностический тест LHC-CIDI-5
    The interviewer will start by asking the respondent's age and significant personal experiences, which is expected to take 15 minutes. Remembering and recording the experiences provide cognitive engagement and information which can further serve as memory cues for respondents in the following screening of CIDI-5. Subsequently, the respondents will proceed to the screening section for CIDI-5 and will refer to the completed calendar from the LHC section when they are asked to report lifetime experi

Первичные конечные точки

  • Depression [Срок оценки: Immediately following intervention or recruitment]
  • Persistent Depression [Срок оценки: Immediately following intervention or recruitment]
  • Self Harm [Срок оценки: Immediately following intervention or recruitment]
  • High Mood [Срок оценки: Immediately following intervention or recruitment]
  • Worry and Anxiety [Срок оценки: Immediately following intervention or recruitment]
  • Anger Attacks [Срок оценки: Immediately following intervention or recruitment]
  • Panic Attacks [Срок оценки: Immediately following intervention or recruitment]
  • Obsessions and Compulsions [Срок оценки: Immediately following intervention or recruitment]
  • Stressful Experiences [Срок оценки: Immediately following intervention or recruitment]
  • Tobacco, Alcohol, and Drugs [Срок оценки: Immediately following intervention or recruitment]

Критерии участия

Критерии включения

  • All household members aged 25 years old and over are randomly sampled from the Census and Statistics Department List of Quarters
  • Live in the address sampled from the Census and Statistics Department List of Quarters
  • Reside in Hong Kong for at least six months in the past year
  • Able to read and communicate in Chinese or English
  • Without linguistic or cognitive difficulties

Критерии исключения

  • Domestic workers

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Дизайн исследования

Модель наблюдения
Экологическое

Центры проведения

Гонконг · 1 центр
  • The University of Hong Kong — Гонконг

Публикации

  • Amro I, Ali A, Hassan MHMO, Al Shawwaf M, Alhassan A, Al Bahari D, El Fakki H, Hijawi Z, Aly S, Amin A, Mohammed R, Nofal M, Abdelkader M, Salman S, Currie J, Alabdulla M, Sampson NA, First M, Kessler RC, Woodruff PW, Khaled SM. Design and field procedures for the clinical reappraisal of the Composite International Diagnostic Interview version 3.3 in Qatar's national mental health study. Int J Met PMID 36654500
  • Axinn WG, Chardoul S, Gatny H, Ghimire DJ, Smoller JW, Zhang Y, Scott KM. Using life history calendars to improve measurement of lifetime experience with mental disorders. Psychol Med. 2020 Feb;50(3):515-522. doi: 10.1017/S0033291719000394. Epub 2019 Mar 11. PMID 30854987

Идентификаторы

NCT: NCT06804525 · UW 24-771 · 2024-0089-004

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗